Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

icons/content-types/video webinar

In vitro biochemical assays make possible the high throughput screening (HTS) of large compound libraries. A successful HTS campaign is typically viewed as one that identifies large numbers of diverse chemical series hits as potential starting points...

icons/content-types/article article

CDMOs that routinely handle highly potent compounds must raise the bar for containment, safety, and industrial hygiene. Diverse capabilities across chemistries, purification technologies, and analytical techniques — combined with the ability to sup...

icons/content-types/article article

It is no coincidence that the booms in prefilled syringes (PFS) and biologic medicines are happening at the same time – the two are intrinsically linked. Innovative biologic medicines demand innovative delivery systems to match, and as the utility...

icons/content-types/article article

The pre-filled syringe (PFS) space is one of the fastest growing pharma sectors, expected to be worth $9.7bn by 2025, or 9% CAGR. Compared with traditional vial delivery systems, PFS offers greater patient safety and lower manufacturing costs – bu...

icons/content-types/article article

As the COVID-19 outbreak continues to spread across the globe, Curia is diligently monitoring the latest developments.  As such, Curia has established a companywide taskforce to assure a coordinated response across our global network, focusing on em...

icons/content-types/article article

Syringes have been a mainstay of drug delivery for decades – but, as with many other aspects of healthcare, they have recently undergone something of a revolution. The growth of biological medications, the ever-increasing focus on safety, and a...

icons/content-types/video webinar

In this free webinar, the featured speaker will explore the key advances and critical hurdles for translating these emerging molecular biology technologies into real-world applications and commercial processes. Topics for discussion will include: a b...

icons/content-types/article article

Xtalks spoke with Dr. Steef Boerrigter, a senior research scientist at Curia and an expert at materials science. He has extensive experience with experimental screening technologies for polymorphs, salts and cocrystals and has developed computationa...

icons/content-types/video webinar

Curia offers more than 240 high-quality, competitively priced APIs and intermediates, including generics, that cover a variety of therapeutic areas. Take a look at our recently filed DMFs.

icons/content-types/video webinar

Oftentimes, the HPAPI sphere places the spotlight on manufacturing due to the containment challenges on large scale however; handling and containment strategies are also relevant in manufacture support roles such as chemical development, analytical...

icons/content-types/video webinar

The objective of this webinar is to address United States Pharmacopeia (USP) and FDA regulatory trends to demonstrate how to integrate various analytical tests into a robust program that addresses product integrity/compatibility throughout the produc...

icons/content-types/video webinar

Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid form. It is critical to understand the solid form l...